GAAP

Masimo Shares Final Thoughts Ahead of September 19 Annual Meeting Where Everything is at Stake

Retrieved on: 
Monday, September 16, 2024
Medical Devices, Hardware, Health, Technology, Health Technology, Egan-Jones Ratings Company, Investment, DRIVE, Committee, GAAP, Glass, Medtech, JV, Potential, Patient, EPS, Growth, Court, Wear OS, Annual general meeting, Corporation, Glass Lewis, Heart, MASI, District court, Contempt, Algorithm, Spin, ISS, Wear, Partnership, GOLD, Sale, Appendix, Holding company

There are just nine months until our next Annual Meeting when you will get to vote again on me and other non-Politan directors currently on the Board.

Key Points: 
  • There are just nine months until our next Annual Meeting when you will get to vote again on me and other non-Politan directors currently on the Board.
  • Masimo has announced a monumental partnership with Google to develop a state-of-the-art reference platform for Wear OS by Google™ smartwatches2.
  • Declassification of the Masimo Board has already started and will be complete at the 2026 Annual Meeting.
  • The September 19, 2024 Annual Meeting is fast approaching, and stockholders’ votes matter.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Starbucks, Sage, Outset Medical, and Super Micro and Encourages Investors to Contact the Firm

Retrieved on: 
Sunday, September 15, 2024
Zuranolone, SMCI, SBUX, GAAP, Supermicro, Hindenburg Research, FY, FDA, Defendant, Sage, Complaint, PD, P.C, Hindenburg, MDD, MCI, Starbucks, Hemofiltration, Pharmaceutical industry

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • Additional information about each case can be found at the link provided.
  • For more information on the Outset Medical class action go to: https://bespc.com/cases/OM
    According to the complaint, on August 27, 2024, Hindenburg Research unveiled a short report on SMCI.
  • For more information on the Super Micro class action go to: https://bespc.com/cases/SMCI

Faruqi & Faruqi Reminds Starbucks Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SBUX

Retrieved on: 
Friday, September 13, 2024
SBUX, GAAP, Advertising, FY, LLP, Court, Reinvention, Cryptocurrency

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Starbucks Corporation (“Starbucks” or the “Company”) (NASDAQ: SBUX) and reminds investors of the October 28, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Starbucks’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
  • To learn more about the Starbucks class action, go to www.faruqilaw.com/SBUX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.

EVI Industries Reports Fourth Quarter and Fiscal Year Results, Including Record $33M in Operating Cash Flows

Retrieved on: 
Thursday, September 12, 2024
Consulting, Machinery, Professional Services, Manufacturing, Investment, Tax, GAAP, Security (finance), Growth, Knowledge, Exercise, Acquisition, OEM, Family, Compensation, Interest, EVI, Fine chemical

EVI Industries, Inc. (NYSE American: EVI) announced its operating results for the three- and twelve-month periods ended June 30, 2024, including record gross profit, record gross margin, and record operating cash flows for fiscal 2024, and record gross margin and record operating cash flows for the three-month period ended June 30, 2024.

Key Points: 
  • EVI Industries, Inc. (NYSE American: EVI) announced its operating results for the three- and twelve-month periods ended June 30, 2024, including record gross profit, record gross margin, and record operating cash flows for fiscal 2024, and record gross margin and record operating cash flows for the three-month period ended June 30, 2024.
  • The three-year compounded annual revenue growth rate for businesses the Company has owned for at least four years is 8.0%.
  • During fiscal 2024, the Company set another fiscal year record for gross profit at $105 million and another fiscal year record for gross margin at 30%.
  • During fiscal 2024, the Company generated a record $33 million in operating cash flow, a $32 million increase over prior year, and a record $12 million in operating cash flow during the fourth quarter of fiscal 2024, a $4.8 million increase compared to the same period of the prior fiscal year.

Adobe Reports Record Revenue in Q3 Fiscal 2024

Retrieved on: 
Thursday, September 12, 2024
Software, Technology, Internet, Consumer Electronics, Cloud, Adobe Creative Cloud, GAAP, Digital media, Growth, ADBE, RPO, CFO, Creative

Adobe (Nasdaq:ADBE) today reported financial results for its third quarter fiscal year 2024 ended Aug. 30, 2024.

Key Points: 
  • Adobe (Nasdaq:ADBE) today reported financial results for its third quarter fiscal year 2024 ended Aug. 30, 2024.
  • "Adobe's record Q3 performance is a testament to our relentless innovation and commitment to delivering value to our customers,” said Shantanu Narayen, chair and CEO, Adobe.
  • Net new Digital Media Annualized Recurring Revenue (“ARR”) was $504 million, exiting the quarter with Digital Media ARR of $16.76 billion.
  • The following table summarizes Adobe’s fourth quarter fiscal year 2024 targets:

IBEX Announces Record Fourth Quarter and Fiscal Year 2024 Financial Results

Retrieved on: 
Thursday, September 12, 2024
Investment, GAAP, Growth, Travel, FY, EPS, AI, Transport, Capital expenditure, CFO, BPO, Human, Pharmaceutical industry

“We achieved record results across key financial metrics including full year net income, EPS, adjusted net income, adjusted EPS, and free cash flow, and had a strong fourth quarter that exceeded our expectations,” said Bob Dechant, ibex CEO.

Key Points: 
  • “We achieved record results across key financial metrics including full year net income, EPS, adjusted net income, adjusted EPS, and free cash flow, and had a strong fourth quarter that exceeded our expectations,” said Bob Dechant, ibex CEO.
  • “Our revenues for the fourth quarter were encouraging, and we are happy to report that we pivoted back to year-on-year growth,” said Dechant.
  • In the last half of fiscal year 2024, we delivered an adjusted EBITDA margin of 14.8%, placing ibex among the top performers of our industry.
  • IBEX Limited will host a conference call and live webcast to discuss its fourth quarter of fiscal year 2024 financial results at 4:30 p.m. Eastern Time today, September 12, 2024.

Brokerage Labor Cost Per Transaction Exceeds $900 thru mid-year 2024

Retrieved on: 
Thursday, September 12, 2024
Cloud, Real estate, GAAP, Forecasting, Rigidity, CFO, Century, Software, Spotlight, Labour, Insurance, KPI, Marketing

In this study, the average labor cost per transaction was $919.50 for the first 6 months of 2024.

Key Points: 
  • In this study, the average labor cost per transaction was $919.50 for the first 6 months of 2024.
  • In the companies studied, as the number of closed transaction sides increased, total labor costs did not increase.
  • The study shows that companies maintain static labor cost expenditures even when transaction sides or agent count are trending lower.
  • Since labor is the number one cost to brokerages, the industry needs a new way to benchmark for labor cost that isn't based on transaction count or agent count.

Belden Expands on Solutions Transformation Strategy and Provides Long-Term Financial Framework Through 2028

Retrieved on: 
Thursday, September 12, 2024
Other Manufacturing, Technology, Security, Engineering, Other Technology, Software, Manufacturing, Networks, Internet, Hardware, BDC, Bank statement, GAAP, Improper integral, EPS, Growth, Inc., Acquisition, Belden Incorporated, Adjustment, Public expenditure, Name, Automation, Share repurchase

As we advance our transformation journey, growth in Belden Solutions will further enable improved operating and financial performance.”

Key Points: 
  • As we advance our transformation journey, growth in Belden Solutions will further enable improved operating and financial performance.”
    “At our last investor day in 2022, we set ambitious targets for the organization to achieve through 2025.
  • Progress towards this target demonstrates the benefits of our Solutions transformation and that our business can consistently grow and increase earnings.
  • As Belden continues to advance forward with solutions focused on data infrastructure, today Belden announced a change to the names of its two reportable segments.
  • The former Industrial Automation Solutions segment will be renamed Automation Solutions and the former Enterprise Solutions segment will be renamed Smart Infrastructure Solutions.

Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer

Retrieved on: 
Thursday, September 12, 2024
Natural Resources, Other Retail, Health, Hemp, Cannabis, Retail, Forest Products, Other Health, GAAP, MBA, Economics, Growth, Olís, CFO, Cresco Labs, SOX, Michigan State University, TJX Companies, Financial management, Multimedia, Schuler

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that Dennis Olis, Chief Financial Officer, will retire from Cresco Labs after a planned transition to Sharon Schuler, an experienced financial and strategy executive.

Key Points: 
  • Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that Dennis Olis, Chief Financial Officer, will retire from Cresco Labs after a planned transition to Sharon Schuler, an experienced financial and strategy executive.
  • View the full release here: https://www.businesswire.com/news/home/20240912302903/en/
    Financial executive Sharon Schuler joins Cresco Labs and will succeed retiring CFO Dennis Olis (Photo: Business Wire)
    Schuler recently joined Cresco Labs while preparing to take the role of Chief Financial Officer upon Olis’s departure.
  • “Dennis has been CFO for Cresco Labs during a period of tremendous growth, profitability improvement and companywide maturation,” said Charlie Bachtell, CEO of Cresco Labs.
  • “He has been instrumental in laying the foundation of Cresco Labs, helping us build the capabilities and the financial position that will support stability and growth for years to come.”
    “It has been an honor to be entrusted with guiding the financial strategy of Cresco Labs through such transformative years," said Dennis Olis, Chief Financial Officer.

Streamline Health® Reports Fiscal Second Quarter 2024 Financial Results

Retrieved on: 
Wednesday, September 11, 2024
GAAP, Growth, Automation, Streamline, Workforce, Interest, Software as a service, ACV, Food delivery

Fiscal Second Quarter and Six-Months Ended July 31, 2024 GAAP Financial Results

Key Points: 
  • Fiscal Second Quarter and Six-Months Ended July 31, 2024 GAAP Financial Results
    Total revenue for the second quarter of fiscal 2024 was $4.5 million compared to $5.8 million during the second quarter of fiscal 2023.
  • SaaS revenue for the second quarter of fiscal 2024 totaled $3.1 million, 69% of total revenue, compared to SaaS revenue of $3.5 million, 61% of total revenue during the second quarter of fiscal 2023.
  • Net loss for the second quarter of fiscal 2024 was ($2.8 million) compared to a net loss of ($2.5 million) during the second quarter of fiscal 2023.
  • Fiscal Second Quarter and Six Months Ended July 31, 2024 Non-GAAP Financial Results
    Adjusted EBITDA for the second quarter of fiscal 2024 was ($0.3 million) compared to ($0.9 million) during the second quarter of fiscal 2023.